No — real product (enclomiphene from FDA-registered compounding pharmacies), real prescribing process (licensed physicians evaluating lab work), real refunds available within standard policy windows. The persistent complaint pattern across Hims reviews — subscription cancellation friction — is a real watch point but not a scam pattern. Customers receive the product. Customers receive the medical service they paid for. Cancellation friction is a customer-service issue, not a legitimacy issue. Document everything when subscribing and use card-issuer dispute mechanisms if cancellation routes don't respond.

How long does Hims-TRT take to ship?

Hims shipping is among the faster in telehealth — typical timeline is 2–5 business days from script approval to delivery. The full intake-to-first-dose path is roughly 1–2 weeks: same-day intake, prescriber consult within 24–48 hours, lab order issued, lab draw within the week, lab review and shipment within the following week. The total is faster than many dedicated TRT clinics because Hims has optimized for high-volume telehealth fulfillment.

Does Hims-TRT accept insurance?

No — Hims is a cash-pay subscription telehealth service and does not bill insurance for TRT, ED, hair loss, or weight loss medications. The lab work specifically can sometimes be billed to insurance through the lab partner (LabCorp or Quest), but you'd be responsible for managing those claims yourself. The trade-off Hims makes: lowest entry pricing in exchange for cash-pay only. If you have strong insurance coverage for hormone evaluation through an in-network endocrinologist or urologist, the insurance-billed path may be cheaper but with longer wait times for appointments.

Is Hims-TRT (enclomiphene) safe?

Enclomiphene has a different safety profile than injectable testosterone. As a selective estrogen receptor modulator (SERM), enclomiphene stimulates natural testosterone production rather than replacing it — preserving fertility and avoiding the testicular shutdown that comes with exogenous TRT. Side effects can include mood changes, headaches, and visual disturbances (rare). Hims requires hormone-axis labs (total T, free T, LH, FSH, estradiol) before prescribing and at follow-up. The watch point isn't safety per se — it's whether enclomiphene is the appropriate medication for your specific hormone-axis state, which the labs help determine.

Hims enclomiphene vs injectable TRT — which is better for me?

Different medications for different cases. Enclomiphene (a SERM) stimulates your natural testosterone production by blocking estrogen feedback at the hypothalamus — preserving fertility and avoiding testicular shutdown. Injectable testosterone replaces the hormone directly — more reliable across all severities, more potent effect, but suppresses natural production and fertility. Pick enclomiphene if you have mild low T (total T in the 250–400 ng/dL range), intact testicular function, and want fertility preservation as a priority. Pick injectable TRT if you have moderate-to-severe low T, fertility is not a priority, or enclomiphene hasn't produced adequate response after 8–12 weeks. The labs and a knowledgeable prescriber determine the right path.

ALPHAHEALTH FINDERFind Online Providers

Hims TRT & Testosterone Review

Name: Hims — AHF Editorial Review
Brand: Hims
Rating: 3.9 (1 reviews)

From $4 · Free consult · 4.2★ on Trustpilot · All 50 States

Get Free Consultation Read our review

Trustpilot

4.2

7,811 verified reviews

7,811+ Verified Reviews

LegitScript Approved

Independently Reviewed

Editorially Rated

AHF Editorial Rating

3.9/5

Lowest-priced enclomiphene TRT-alternative at scale — fits a narrow case, not full testosterone replacement.

AHF Editorial Team·Last updated June 11, 2026·Independent review · No vendor-controlled edits

How we rate providers

Services Offered

What Hims treats

Fit Check

Is Hims the right fit for you?

Who it's for

Men with mild low T (total T in the 250–400 ng/dL range) who haven't tried first-line interventions and want a fertility-preserving alternative to standard TRT
Fertility-preservation candidates who want to maintain natural testosterone production (enclomiphene stimulates the HPT axis rather than replacing testosterone)
Hims subscribers already on ED / hair loss / weight loss who want to add TRT-category treatment under their existing account
Price-sensitive shoppers comfortable with the modality limitation ($99/month is the lowest-priced TRT-category entry in the market)

Who it's not for

Anyone needing INJECTABLE testosterone replacement — Hims is enclomiphene-only today (injectable TRT planned for 2026)
Men with moderate to severe hypogonadism — enclomiphene works for mild cases responding to HPT-axis stimulation, not for cases requiring exogenous T
Patients with primary hypogonadism (testicular failure) where the HPT axis cannot respond to enclomiphene
Anyone with prior cancellation friction on Hims subscriptions — the persistent customer-service complaint pattern is real and worth weighing

What to expect

Your first 3 months with Hims

01Day 1

Same-day intake on the Hims platform — short questionnaire covering symptoms, medical history, and current medications. No upfront cost, free consultation. The TRT product flow is more abbreviated than dedicated TRT clinics because enclomiphene prescribing has narrower screening requirements than injectable TRT.

02Week 1

Video or async consult with a licensed physician. Lab order issued covering hormone panel (total T, free T, LH, FSH, estradiol) — the panel is more focused than what a dedicated TRT clinic might pull, because enclomiphene prescribing requires specific hormone-axis markers rather than the broader workup needed for injectable TRT. Local LabCorp or Quest draw; results in 2–3 business days.

03Month 1

Lab review confirms candidacy for enclomiphene. First prescription shipped 2–5 days from script approval (Hims shipping is faster than many competitors). Begin oral enclomiphene typically at 12.5–25 mg every other day. Effects on energy and libido often emerge by week 3–4; testosterone level changes typically measurable by week 6–8.

04Month 3

Follow-up labs at 8–12 weeks measure hormone-axis response — total T, free T, LH, FSH. If responding (target total T typically 500–800 ng/dL on enclomiphene), maintain dose. If not responding adequately, the conversation shifts to whether injectable TRT through a dedicated clinic is the appropriate next step. Hims will refer out for cases that need exogenous testosterone (since they don't yet offer injectable).

Compare

Hims vs the alternatives

vs.

PeterMD

[PeterMD](/online-providers/trt-testosterone/petermd) offers the full range of TRT modalities — injectable testosterone cypionate (the standard of care for full TRT), oral enclomiphene, and topical cream. Hims is enclomiphene-only for TRT today. PeterMD is also TRT-focused as a primary product line; Hims-TRT is one of many categories Hims serves. For cost-comparable enclomiphene only, the two are close ($99/mo Hims vs PeterMD's $278/2-month enclomiphene supply — Hims is cheaper per month). For anyone needing injectable TRT or the option to switch modalities, PeterMD wins by default. AHF rates PeterMD 4.3 and Hims (TRT) 3.9 — gap reflects the modality limitation more than legitimacy concerns.

From $62.50·44+ States

4.2

Trustpilot Rating

Starting Price

All 50 States

State Coverage

2-5 Days

Turnaround

Honest Breakdown

What Works Well

Extremely affordable ED meds starting at $4/dose
Massive scale with 2.5M+ active subscribers
Free online consultations included
Publicly traded company (NYSE: HIMS) - established trust
Available in all 50 states
Wide range of treatments in one platform
Discreet packaging and fast shipping
Chewable ED options (Hard Mints) available

Watch Points

Subscription cancellation can be difficult
Mixed customer service reviews
No injectable TRT yet (coming 2026)
Uses compounded GLP-1 (not brand-name Ozempic/Wegovy)

See if Hims is right for you — Free Consultation

Real Questions

What people actually ask about Hims

Yes — Hims operates as a publicly traded US telehealth platform (NYSE: HIMS) with 2.5M+ subscribers and $2.35B in 2025 revenue. Licensed physicians prescribe in each state served, FDA-registered pharmacies dispense medications, and the platform clears every basic legitimacy check for telehealth prescribing. The watch point isn't legitimacy — it's the modality. Hims-TRT today is enclomiphene-only, which is legitimate medicine for the right candidate but not what most users mean when they search for "TRT review." Editorial honesty requires being clear that this is a fertility-preserving alternative to TRT, not testosterone replacement itself.

Ready to start with Hims?

Free consultation. Independently reviewed. Board-certified physicians.

Get Free Consultation

Secure telemedicine · HIPAA compliant · Cancel anytime

4.2★From $4 · All 50 States

Start with Hims